Loading...
LongevityFrontier ResearchResearch phase
Gene Therapy for Longevity
Experimental gene therapies targeting follistatin, telomerase, Klotho, and other longevity genes
4.035 verified reviews
Single treatment$25,000 - $100,000+This therapy is still emerging. Gabriel can help you understand the evidence and identify legitimate research or waitlist pathways.
Visit PreviewLongevity
During the visit
Extensive screening and medical evaluation (not available at standard clinics)
Gene therapy administered via viral vector (AAV) injection — typically one-time
Post-treatment monitoring for immune response and gene expression changes
Effects develop over weeks to months as gene expression changes
Duration
Single treatment
Starting at
$25,000
Practitioner access
Research-only
Category
Longevity
About this treatment
What this treatment is designed to do
Longevity gene therapy represents the most frontier edge of anti-aging medicine — directly modifying gene expression to combat aging at its source. Several gene therapy approaches are in development or early clinical use:
Follistatin gene therapy increases muscle mass, reduces body fat, and improves metabolic health by upregulating follistatin (which inhibits myostatin, the muscle growth limiter). BioViva Sciences' CEO Elizabeth Parrish was the first person to undergo follistatin and telomerase gene therapy in 2015 and has reported measurable telomere lengthening.
Telomerase (hTERT) gene therapy aims to reactivate the enzyme that lengthens telomeres — the protective caps on chromosomes that shorten with age. Shorter telomeres are associated with aging and disease, and restoring telomerase activity could theoretically reverse cellular aging.
Klotho protein therapy (both gene therapy and direct protein infusion) targets the anti-aging Klotho gene, which declines with age. Research at UCSF has shown that Klotho protein improves cognitive function in aging mice and protects against kidney disease, cardiovascular disease, and neurodegeneration.
These therapies are currently available only through select research programs, clinical trials, or medical tourism destinations. They represent the frontier of where longevity medicine is heading.
Visit flow
What happens during the session
1
Extensive screening and medical evaluation (not available at standard clinics)
2
Gene therapy administered via viral vector (AAV) injection — typically one-time
3
Post-treatment monitoring for immune response and gene expression changes
4
Effects develop over weeks to months as gene expression changes
5
Currently available primarily through clinical trials or offshore programs
6
This is experimental medicine — long-term safety data is still being collected
Best for
Why people usually choose this
Pioneering individuals willing to participate in frontier medicine
Those with access to clinical trials or approved research programs
High-net-worth individuals pursuing the most advanced longevity interventions
People comfortable with experimental risk-benefit profiles
Key outcomes
What people hope to improve
Targets aging at the genetic level — the most fundamental intervention possible
Follistatin: increases muscle mass and reduces body fat
Telomerase: may reverse telomere shortening (a hallmark of aging)
Klotho: improves cognitive function and protects against age-related diseases
Gabriel intelligence
How Gabriel makes this treatment more actionable
Treatment fit
Root-cause context before you book
Gabriel can help decide whether gene therapy for longevity fits your symptoms, labs, and recovery goals before you spend money on a session.
Protocol pairing
Connect sessions to a real plan
Gabriel can pair this with diagnostics, supplements, peptides, and follow-up cadence so it fits into a real protocol instead of sitting in isolation.
Practitioner match
Find the right clinic, not just the nearest one
Gabriel uses trust, treatment fit, and modality overlap to surface practitioners who are more likely to be a strong match for this exact treatment path.
Evidence & safety
What to know before committing
Experimental. Animal studies show remarkable results. Human data is extremely limited — primarily case reports and early-phase trials. AAV gene therapy has known risks including immune reactions. Long-term safety unknown. This is frontier medicine by definition. Only pursue through legitimate research institutions.
Related treatments
Similar treatments people compare next
Use these when you want adjacent options in the same category before deciding what to book.
Not sure if this treatment is the right next move?
Tell Gabriel what you are dealing with and what you have already tried. You will get a more useful answer than a generic treatment directory can give.